Viewing Study NCT00120861


Ignite Creation Date: 2025-12-24 @ 12:46 PM
Ignite Modification Date: 2025-12-31 @ 7:44 PM
Study NCT ID: NCT00120861
Status: COMPLETED
Last Update Posted: 2010-06-10
First Post: 2005-07-11
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Valopicitabine Alone and Together With Pegylated Interferon in Patients With Chronic Hepatitis C Who Have Failed to Respond to Standard Therapy
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module